Amino Silicone Oil Market In Global
Amino Silicone Oil is devoted to the basic ingredients of the textile softening agent. It has the ... Read More
RNAi for Therapeutic Market - Global Outlook and Forecast 2023-2028
1 Introduction to Research & Analysis Reports
1.1 RNAi for Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNAi for Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNAi for Therapeutic Overall Market Size
2.1 Global RNAi for Therapeutic Market Size: 2021 VS 2028
2.2 Global RNAi for Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNAi for Therapeutic Players in Global Market
3.2 Top Global RNAi for Therapeutic Companies Ranked by Revenue
3.3 Global RNAi for Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 RNAi for Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies RNAi for Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNAi for Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 RNAi for Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 RNAi for Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global RNAi for Therapeutic Market Size Markets, 2021 & 2028
4.1.2 siRNA
4.1.3 miRNA
4.1.4 shRNA
4.2 By Type - Global RNAi for Therapeutic Revenue & Forecasts
4.2.1 By Type - Global RNAi for Therapeutic Revenue, 2017-2022
4.2.2 By Type - Global RNAi for Therapeutic Revenue, 2023-2028
4.2.3 By Type - Global RNAi for Therapeutic Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNAi for Therapeutic Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Cardiovascular
5.1.4 HBV
5.1.5 Others
5.2 By Application - Global RNAi for Therapeutic Revenue & Forecasts
5.2.1 By Application - Global RNAi for Therapeutic Revenue, 2017-2022
5.2.2 By Application - Global RNAi for Therapeutic Revenue, 2023-2028
5.2.3 By Application - Global RNAi for Therapeutic Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global RNAi for Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global RNAi for Therapeutic Revenue & Forecasts
6.2.1 By Region - Global RNAi for Therapeutic Revenue, 2017-2022
6.2.2 By Region - Global RNAi for Therapeutic Revenue, 2023-2028
6.2.3 By Region - Global RNAi for Therapeutic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America RNAi for Therapeutic Revenue, 2017-2028
6.3.2 US RNAi for Therapeutic Market Size, 2017-2028
6.3.3 Canada RNAi for Therapeutic Market Size, 2017-2028
6.3.4 Mexico RNAi for Therapeutic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe RNAi for Therapeutic Revenue, 2017-2028
6.4.2 Germany RNAi for Therapeutic Market Size, 2017-2028
6.4.3 France RNAi for Therapeutic Market Size, 2017-2028
6.4.4 U.K. RNAi for Therapeutic Market Size, 2017-2028
6.4.5 Italy RNAi for Therapeutic Market Size, 2017-2028
6.4.6 Russia RNAi for Therapeutic Market Size, 2017-2028
6.4.7 Nordic Countries RNAi for Therapeutic Market Size, 2017-2028
6.4.8 Benelux RNAi for Therapeutic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia RNAi for Therapeutic Revenue, 2017-2028
6.5.2 China RNAi for Therapeutic Market Size, 2017-2028
6.5.3 Japan RNAi for Therapeutic Market Size, 2017-2028
6.5.4 South Korea RNAi for Therapeutic Market Size, 2017-2028
6.5.5 Southeast Asia RNAi for Therapeutic Market Size, 2017-2028
6.5.6 India RNAi for Therapeutic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America RNAi for Therapeutic Revenue, 2017-2028
6.6.2 Brazil RNAi for Therapeutic Market Size, 2017-2028
6.6.3 Argentina RNAi for Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNAi for Therapeutic Revenue, 2017-2028
6.7.2 Turkey RNAi for Therapeutic Market Size, 2017-2028
6.7.3 Israel RNAi for Therapeutic Market Size, 2017-2028
6.7.4 Saudi Arabia RNAi for Therapeutic Market Size, 2017-2028
6.7.5 UAE RNAi for Therapeutic Market Size, 2017-2028
7 Players Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Corporate Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.1.4 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.1.5 Alnylam Pharmaceuticals Key News
7.2 Arbutus Biopharma (Tekmira)
7.2.1 Arbutus Biopharma (Tekmira) Corporate Summary
7.2.2 Arbutus Biopharma (Tekmira) Business Overview
7.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Major Product Offerings
7.2.4 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.2.5 Arbutus Biopharma (Tekmira) Key News
7.3 Arrowhead
7.3.1 Arrowhead Corporate Summary
7.3.2 Arrowhead Business Overview
7.3.3 Arrowhead RNAi for Therapeutic Major Product Offerings
7.3.4 Arrowhead RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.3.5 Arrowhead Key News
7.4 Dicerna Pharmaceuticals
7.4.1 Dicerna Pharmaceuticals Corporate Summary
7.4.2 Dicerna Pharmaceuticals Business Overview
7.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.4.4 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.4.5 Dicerna Pharmaceuticals Key News
7.5 Mirna Therapeutics
7.5.1 Mirna Therapeutics Corporate Summary
7.5.2 Mirna Therapeutics Business Overview
7.5.3 Mirna Therapeutics RNAi for Therapeutic Major Product Offerings
7.5.4 Mirna Therapeutics RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.5.5 Mirna Therapeutics Key News
7.6 Quark Pharmaceuticals
7.6.1 Quark Pharmaceuticals Corporate Summary
7.6.2 Quark Pharmaceuticals Business Overview
7.6.3 Quark Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.6.4 Quark Pharmaceuticals RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.6.5 Quark Pharmaceuticals Key News
7.7 RXi Pharmaceuticals
7.7.1 RXi Pharmaceuticals Corporate Summary
7.7.2 RXi Pharmaceuticals Business Overview
7.7.3 RXi Pharmaceuticals RNAi for Therapeutic Major Product Offerings
7.7.4 RXi Pharmaceuticals RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.7.5 RXi Pharmaceuticals Key News
7.8 Silence Therapeutics
7.8.1 Silence Therapeutics Corporate Summary
7.8.2 Silence Therapeutics Business Overview
7.8.3 Silence Therapeutics RNAi for Therapeutic Major Product Offerings
7.8.4 Silence Therapeutics RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.8.5 Silence Therapeutics Key News
7.9 Benitec Biopharma
7.9.1 Benitec Biopharma Corporate Summary
7.9.2 Benitec Biopharma Business Overview
7.9.3 Benitec Biopharma RNAi for Therapeutic Major Product Offerings
7.9.4 Benitec Biopharma RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.9.5 Benitec Biopharma Key News
7.10 miRagen Therapeutics
7.10.1 miRagen Therapeutics Corporate Summary
7.10.2 miRagen Therapeutics Business Overview
7.10.3 miRagen Therapeutics RNAi for Therapeutic Major Product Offerings
7.10.4 miRagen Therapeutics RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.10.5 miRagen Therapeutics Key News
7.11 Sylentis
7.11.1 Sylentis Corporate Summary
7.11.2 Sylentis Business Overview
7.11.3 Sylentis RNAi for Therapeutic Major Product Offerings
7.11.4 Sylentis RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.11.5 Sylentis Key News
7.12 Gradalis
7.12.1 Gradalis Corporate Summary
7.12.2 Gradalis Business Overview
7.12.3 Gradalis RNAi for Therapeutic Major Product Offerings
7.12.4 Gradalis RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.12.5 Gradalis Key News
7.13 Sirnaomics
7.13.1 Sirnaomics Corporate Summary
7.13.2 Sirnaomics Business Overview
7.13.3 Sirnaomics RNAi for Therapeutic Major Product Offerings
7.13.4 Sirnaomics RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.13.5 Sirnaomics Key News
7.14 Silenseed
7.14.1 Silenseed Corporate Summary
7.14.2 Silenseed Business Overview
7.14.3 Silenseed RNAi for Therapeutic Major Product Offerings
7.14.4 Silenseed RNAi for Therapeutic Revenue in Global Market (2017-2022)
7.14.5 Silenseed Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. RNAi for Therapeutic Market Opportunities & Trends in Global Market
Table 2. RNAi for Therapeutic Market Drivers in Global Market
Table 3. RNAi for Therapeutic Market Restraints in Global Market
Table 4. Key Players of RNAi for Therapeutic in Global Market
Table 5. Top RNAi for Therapeutic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global RNAi for Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global RNAi for Therapeutic Revenue Share by Companies, 2017-2022
Table 8. Global Companies RNAi for Therapeutic Product Type
Table 9. List of Global Tier 1 RNAi for Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNAi for Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global RNAi for Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - RNAi for Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - RNAi for Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global RNAi for Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - RNAi for Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - RNAi for Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global RNAi for Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global RNAi for Therapeutic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global RNAi for Therapeutic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America RNAi for Therapeutic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America RNAi for Therapeutic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe RNAi for Therapeutic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe RNAi for Therapeutic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia RNAi for Therapeutic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia RNAi for Therapeutic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America RNAi for Therapeutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America RNAi for Therapeutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa RNAi for Therapeutic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa RNAi for Therapeutic Revenue, (US$, Mn), 2023-2028
Table 30. Alnylam Pharmaceuticals Corporate Summary
Table 31. Alnylam Pharmaceuticals RNAi for Therapeutic Product Offerings
Table 32. Alnylam Pharmaceuticals RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 33. Arbutus Biopharma (Tekmira) Corporate Summary
Table 34. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product Offerings
Table 35. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 36. Arrowhead Corporate Summary
Table 37. Arrowhead RNAi for Therapeutic Product Offerings
Table 38. Arrowhead RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 39. Dicerna Pharmaceuticals Corporate Summary
Table 40. Dicerna Pharmaceuticals RNAi for Therapeutic Product Offerings
Table 41. Dicerna Pharmaceuticals RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 42. Mirna Therapeutics Corporate Summary
Table 43. Mirna Therapeutics RNAi for Therapeutic Product Offerings
Table 44. Mirna Therapeutics RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 45. Quark Pharmaceuticals Corporate Summary
Table 46. Quark Pharmaceuticals RNAi for Therapeutic Product Offerings
Table 47. Quark Pharmaceuticals RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 48. RXi Pharmaceuticals Corporate Summary
Table 49. RXi Pharmaceuticals RNAi for Therapeutic Product Offerings
Table 50. RXi Pharmaceuticals RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 51. Silence Therapeutics Corporate Summary
Table 52. Silence Therapeutics RNAi for Therapeutic Product Offerings
Table 53. Silence Therapeutics RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 54. Benitec Biopharma Corporate Summary
Table 55. Benitec Biopharma RNAi for Therapeutic Product Offerings
Table 56. Benitec Biopharma RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 57. miRagen Therapeutics Corporate Summary
Table 58. miRagen Therapeutics RNAi for Therapeutic Product Offerings
Table 59. miRagen Therapeutics RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 60. Sylentis Corporate Summary
Table 61. Sylentis RNAi for Therapeutic Product Offerings
Table 62. Sylentis RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 63. Gradalis Corporate Summary
Table 64. Gradalis RNAi for Therapeutic Product Offerings
Table 65. Gradalis RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 66. Sirnaomics Corporate Summary
Table 67. Sirnaomics RNAi for Therapeutic Product Offerings
Table 68. Sirnaomics RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
Table 69. Silenseed Corporate Summary
Table 70. Silenseed RNAi for Therapeutic Product Offerings
Table 71. Silenseed RNAi for Therapeutic Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. RNAi for Therapeutic Segment by Type in 2021
Figure 2. RNAi for Therapeutic Segment by Application in 2021
Figure 3. Global RNAi for Therapeutic Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global RNAi for Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global RNAi for Therapeutic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by RNAi for Therapeutic Revenue in 2021
Figure 8. By Type - Global RNAi for Therapeutic Revenue Market Share, 2017-2028
Figure 9. By Application - Global RNAi for Therapeutic Revenue Market Share, 2017-2028
Figure 10. By Region - Global RNAi for Therapeutic Revenue Market Share, 2017-2028
Figure 11. By Country - North America RNAi for Therapeutic Revenue Market Share, 2017-2028
Figure 12. US RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe RNAi for Therapeutic Revenue Market Share, 2017-2028
Figure 16. Germany RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 17. France RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia RNAi for Therapeutic Revenue Market Share, 2017-2028
Figure 24. China RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 28. India RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America RNAi for Therapeutic Revenue Market Share, 2017-2028
Figure 30. Brazil RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa RNAi for Therapeutic Revenue Market Share, 2017-2028
Figure 33. Turkey RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE RNAi for Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 37. Alnylam Pharmaceuticals RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Arrowhead RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dicerna Pharmaceuticals RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Mirna Therapeutics RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Quark Pharmaceuticals RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. RXi Pharmaceuticals RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Silence Therapeutics RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Benitec Biopharma RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. miRagen Therapeutics RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sylentis RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Gradalis RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Sirnaomics RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Silenseed RNAi for Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report